← Leaderboards
Alexander H Kral
University Of California San Francisco
$17,758,651
Attributed
$20,387,557
Total exposure
13
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.7M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$20,387,557 · 13
By mechanism
R01$19,273,035 · 11
R34$708,167 · 1
R21$406,355 · 1
Top collaborators
- Ricky N Bluthenthal7 shared
- Hope Marie Smiley-Mcdonald1 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Susan M. Kegeles$32,347,017
- Daniel H Ciccarone$10,158,183
- Mary Castle White$3,748,499
Others in their field
Top investigators on “Drug Usage”
- Sten H Vermund · University Of Alabama At Birmingham$107,269,886
- Barbara Driver · Westat, Inc.$95,592,456
- Lloyd D Johnston · University Of Michigan At Ann Arbor$60,310,192
- Richard A Miech · Johns Hopkins University$47,260,070
- Robert J. Ursano · Henry M. Jackson Fdn For The Adv Mil/Med$37,497,358
- Gregory D Kirk · Johns Hopkins University$36,143,536
Research focus
Drug UsageInterviewBaseSamplingSan FranciscoCommunitiesCaliforniaInjecting Drug UserPharmaceutical PreparationsOverdoseImprisonmentResearch PersonnelPersonsDrug UserReportingRisk BehaviorsParticipantPublic Health Medicine (Field)PatternInnovationLinkResponseSiteDesign
Grant awards (40)
Assessing the Reach, Effectiveness, and Implementation of Multiple Interventions$658,368
R01 · FY2025 · DA · contact PI
Pathways to Treatment: Assessing Effectiveness and Implementation of Oregon's Deflection Programs for People who Use Drugs$643,285
R01 · FY2025 · DA
Methamphetamine injection, associated health risk, and causes of overdose deaths.$578,389
R01 · FY2024 · DA · contact PI
Assessing the Reach, Effectiveness, and Implementation of Multiple Harm Reduction Interventions.$171,499
R01 · FY2024 · DA · contact PI
Methamphetamine injection, associated health risk, and causes of overdose deaths.$542,138
R01 · FY2023 · DA · contact PI
Assessing the Reach, Effectiveness, and Implementation of Multiple Harm Reduction Interventions.$2,070,844
R01 · FY2022 · DA · contact PI
Methamphetamine injection, associated health risk, and causes of overdose deaths.$593,895
R01 · FY2022 · DA · contact PI
Preventing injection initiation: The Change The Cycle Randomized Controlled Trial$740,262
R01 · FY2018 · DA
Preventing injection initiation: The Change The Cycle Randomized Controlled Trial$721,002
R01 · FY2017 · DA
Preventing Overdose Mortality among People Exiting Incarceration$218,748
R34 · FY2017 · DA · contact PI
Preventing injection initiation: The Change The Cycle Randomized Controlled Trial$721,261
R01 · FY2016 · DA
Preventing Overdose Mortality among People Exiting Incarceration$238,876
R34 · FY2016 · DA · contact PI
Preventing injection initiation: The Change The Cycle Randomized Controlled Trial$775,205
R01 · FY2015 · DA
Preventing Overdose Mortality among People Exiting Incarceration$250,543
R34 · FY2015 · DA · contact PI
Finding, Testing and Treating High-risk Probationers and Parolees with HIV Administrative Supplement$159,290
R01 · FY2015 · MH · contact PI
Finding, Testing and Treating High-risk Probationers and Parolees with HIV$629,058
R01 · FY2014 · MH · contact PI
Finding, Testing and Treating High-risk Probationers and Parolees with HIV$599,778
R01 · FY2013 · MH · contact PI
Finding, Testing and Treating High-risk Probationers and Parolees with HIV$621,132
R01 · FY2012 · MH · contact PI
Exploratory Research on Late Initiation of Drug Injection$513,017
R01 · FY2012 · DA
Finding, Testing and Treating High-risk Probationers and Parolees with HIV$641,515
R01 · FY2011 · MH · contact PI
Exploratory Research on Late Initiation of Drug Injection$560,652
R01 · FY2011 · DA
Assessing Patterns of HIV Risk Among IDUs in Neighborhood Environments over Time$470,380
R01 · FY2011 · DA · contact PI
Finding, Testing and Treating High-risk Probationers and Parolees with HIV$695,488
R01 · FY2010 · MH · contact PI
Exploratory Research on Late Initiation of Drug Injection$583,128
R01 · FY2010 · DA
Assessing Patterns of HIV Risk Among IDUs in Neighborhood Environments over Time$434,868
R01 · FY2010 · DA · contact PI
International Feasibility Study of Pharmacy-based HIV Prevention: San Francisco$222,846
R21 · FY2010 · DA · contact PI
Assessing Patterns of HIV Risk Among IDUs in Neighborhood Environments over Time$50,024
R01 · FY2010 · DA · contact PI
Qualitative Exploration of Low-Frequency Heroin Injectors Not in Drug Treatment$452,231
R01 · FY2009 · DA · contact PI
Assessing Patterns of HIV Risk Among IDUs in Neighborhood Environments over Time$435,492
R01 · FY2009 · DA · contact PI
International Feasibility Study of Pharmacy-based HIV Prevention: San Francisco$183,509
R21 · FY2009 · DA · contact PI
Correlates of Sexual Risk for HIV/STI Among Women Who Use Methamphetamine$510,211
R01 · FY2008 · DA · contact PI
Qualitative Exploration of Low-Frequency Heroin Injectors Not in Drug Treatment$426,231
R01 · FY2008 · DA · contact PI
Correlates of Sexual Risk for HIV/STI Among Women Who Use Methamphetamine$557,766
R01 · FY2007 · DA · contact PI
Qualitative Exploration of Low-Frequency Heroin Injectors Not in Drug Treatment$420,296
R01 · FY2007 · DA · contact PI
Correlates of Sexual Risk for HIV/STI Among Women Who Use Methamphetamine$494,091
R01 · FY2006 · DA · contact PI
Evaluating Impact of a Resource Center for Drug Users$373,952
R01 · FY2005 · DA
Evaluating Impact of a Resource Center for Drug Users$413,420
R01 · FY2004 · DA
Evaluating Impact of a Resource Center for Drug Users$403,227
R01 · FY2003 · DA
Evaluating Impact of a Resource Center for Drug Users$352,231
R01 · FY2002 · DA
HIV PREVALENCE AND INCIDENCE TRENDS AMONG IDUS 1986-1997$259,409
R01 · FY2000 · DA